U.S. STOCKS ON THE MOVE-PepGen, Turbo Energy, Qualcomm
PepGen, Dyne rise after Novartis' $12 bln deal to buy rival Avidity
US. STOCKS ON THE MOVE-Vertex, IBM, Silver Miners
US. STOCKS ON THE MOVE-Vertex, IBM, silver miners
U.S. STOCKS ON THE MOVE- Birkenstock, CME Group, Citigroup
U.S. STOCKS ON THE MOVE- Birkenstock, CME Group, Citigroup
PepGen shares more than double after muscle disease drug shows promise in trial
Brief: PepGen Prices 31 Million Shares At $3.20 Per Share
Brief: PepGen Announces Highest Mean Splicing Correction Reported In DM1 Patients
Brief: Pepgen Announces Proposed Public Offering
PepGen Inc reports results for the quarter ended June 30 - Earnings Summary
PepGen Inc expected to post a loss of 83 cents a share - Earnings Preview
PepGen to discontinue development of experimental Duchenne therapy; shares drop
PepGen Inc reports results for the quarter ended March 31 - Earnings Summary
PepGen Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: PepGen Q1 EPS USD -0.92
U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealth
U.S. STOCKS ON THE MOVE-Capricor, Wave Life Sciences, EVgo
PepGen slumps after pausing mid-stage study of Duchenne drug